|Day Low/High||80.72 / 81.31|
|52 Wk Low/High||48.83 / 84.00|
Shares of St. Jude Medical (STJ) hit a one-year high of $73.74 on Wednesday after the medical technology developer reported first-quarter earnings that edged analysts' expectations.
TheStreet's Jim Cramer says shares of St. Jude Medical are not done going higher.
Mylan will generate a higher stock price for its shareholders in the coming months, deal or no deal.
In trading on Friday, shares of St. Jude Medical, Inc.
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, St. Jude Medical, Inc.
TheStreet highlights 3 stocks pushing the health services industry lower today.
Analysts may have to raise their price targets and earnings estimates to account for Medtronic's growth potential when including Covidien's assets.
Stocks with insider trader activity include BERY, STJ and FLXS
Trade-Ideas LLC identified St Jude Medical (STJ) as an unusual social activity candidate
Stryker must significantly outperform for all of 2015 just to meet expectations. That's a tall order.
Trade-Ideas LLC identified St Jude Medical (STJ) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate
Trade-Ideas LLC identified St Jude Medical (STJ) as a strong on high relative volume candidate
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.